FDA accepts NDA for unidentified Flamel Tech product

Shares of Flamel Technologies (FLML +3.1%) pop after the FDA accepts the company's second NDA.

A PDUFA date is set for April 28, 2014.

Further analysis here is impeded by the following: "For competitive reasons, the company has decided not to identify the product at this time." (PR)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs